EARLY RECOGNITION, INTENSIVE INTERVENTION AND OTHER PROTECTIVE AND RISK-FACTORS FOR PSYCHOTIC RELAPSE IN PATIENTS WITH FIRST PSYCHOTIC EPISODES IN SCHIZOPHRENIA
Dh. Linszen et al., EARLY RECOGNITION, INTENSIVE INTERVENTION AND OTHER PROTECTIVE AND RISK-FACTORS FOR PSYCHOTIC RELAPSE IN PATIENTS WITH FIRST PSYCHOTIC EPISODES IN SCHIZOPHRENIA, International clinical psychopharmacology, 13, 1998, pp. 7-12
Prevention of relapse is the main purpose of intervention in schizophr
enia. Early studies found that antipsychotic medication protected pati
ents against relapse. Subsequent research showed that family intervent
ion therapy in combination with pharmacotherapy was superior to pharma
cotherapy alone and to individual therapy in combination with pharmaco
therapy. More recent research has focused on expressed-emotion (EE) st
atus and has tried to determine what type of family intervention best
suits patients from particular family types. The Amsterdam relapse pre
vention study investigated the effectiveness of a family behavioral ma
nagement approach combined with standard individual therapy in compari
son with standard individual therapy alone in young, recent-onset, fir
st-or second-episode schizophrenic patients whose families had been ta
ken through a supportive psychoeducational program while the patient w
as in hospital. The standard individual therapy was highly effective,
and further benefit of family intervention could not be demonstrated.
Patients in high-EE families were most at risk of relapse; cannabis ab
use was the second most important risk factor. Among low-EE families,
the relapse rate in the combination intervention group was higher (13%
) than in patients given standard individual therapy alone (0%); this
suggests that psychosocial intervention approaches need to be tailored
to suit family type. Since intensive intervention has a short duratio
n in relation to the length of the disorder in most patients, strategi
es must be developed for continuity of care. Involving family members
in the continuity of care programs may be a crucial step in the delay
or remission of psychotic relapse, combined with maintenance of atypic
al antipsychotic medication. (C) 1998 Rapid Science Ltd.